Compare ClearPoint Neuro Inc (CLPT) vs Match Group Inc (MTCH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ClearPoint Neuro Inc vs Match Group Inc — how do they compare? ClearPoint Neuro Inc trades at $15.7 (market cap $478.63M), while Match Group Inc trades at $38.34 (market cap $8.94B). The key difference: Match Group Inc is far larger — about 18.7× ClearPoint Neuro Inc's market cap, and Match Group Inc pays a 2.09% dividend while ClearPoint Neuro Inc pays none. Which is the better fit depends on your goals.
| CLPT | MTCH | |
|---|---|---|
Market Cap | $478.63M | $8.94B |
Sector | Health | Media |
52-Week High | $29.60 | $39.32 |
52-Week Low | $8.66 | $28.90 |
Enterprise Value | $506.63M | $11.89B |
Dividend Yield | — | 2.09% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ClearPoint Neuro (CLPT) trades at $16.51, down 5.66% on the day, with a bullish technical signal from moving averages but negative profitability. The company reported record Q1 2026 revenue of $36.97M with 25% organic device growth, though it missed EPS estimates with a $0.32 loss. Recent FDA clearance for the Velocity Alpha surgical drill and a partnership with Sungkyunkwan University highlight expansion efforts in neurosurgical navigation and drug delivery.
Outlook remains speculative with 100% analyst buy ratings anticipating gene therapy commercialization upside, but high execution and regulatory risks persist amid consistent losses and negative margins. The stock's valuation at 11.31x sales reflects growth expectations, yet cash burn from operations requires careful monitoring of financing sustainability.
MTCH trades at $38.54, down 0.8% on the day, with a bullish technical signal from moving averages and strong analyst support (17 buy ratings, 0 sell). The company shows solid fundamentals with 4% revenue growth in Q1 2026, an 18.83% net income margin, and positive cash flow trends. Recent news highlights Tinder's turnaround progress and upcoming Q2 2026 earnings announcement on August 4, 2026.
The stock presents upside potential with a consensus price target of $41.63 (8% upside), supported by improving profitability and cash flow generation. Key risks include Tinder's user decline offset by price increases, high debt levels ($3.85B), and competitive pressures in the dating app space. The current valuation at 14.71 P/E appears reasonable given growth prospects.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ClearPoint Neuro Inc
ClearPoint Neuro provides medical devices and software for precise neurosurgical procedures. Its navigation systems allow surgeons to perform minimally invasive brain and spine surgeries with extreme accuracy.
Read more on CLPT →About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →
